Perceptual inference requires the integration of visual features through recurrent processing, the dynamic exchange of information between higher and lower level cortical regions. While animal ...

Anton P Porsteinsson has received grant or research support from Baxter, Bristol-Myers Squibb, Eisai, Elan, Janssen Alzheimer Initiative, Medivation, Pfizer, Toyama and Wyeth. He has served as a ...

Namzaric (donepezil and memantine), also known as MDX-8704, ADS-8704, and Arimenda, is an approved therapy for moderate to severe Alzheimer’s disease. Allergan markets the treatment in the U.S. and ...

"There are currently no approved treatments for DLB, so doctors often use drugs for Alzheimer's disease, such as ...

The lifetime risk of developing Alzheimer’s at age 45 is 1 in 5 for women and 1 in 10 for men, according to the Alzheimer’s ...

Join us on World Alzheimer’s Day 2024 to explore its history, this year’s theme, causes, treatment options, and the critical ...

Alzheimer’s is now the 6th leading cause of death among adults 65 years or older. The progressive condition, characterised by ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...